| Sign In to gain access to subscriptions and/or personal tools. |
Validation of the Spanish, Portuguese and French versions of the Lupus Damage Index questionnaire: data from North and South America, Spain and PortugalGrupo Latino Americano de Estudio de Lupus or Latin America Group for the Study of Lupus, Rosario, Argentina
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, México
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, México
Grupo Latino Americano de Estudio de Lupus or Latin America Group for the Study of Lupus, Rosario, Argentina
Grupo Latino Americano de Estudio de Lupus or Latin America Group for the Study of Lupus, Rosario, Argentina
Grupo Latino Americano de Estudio de Lupus or Latin America Group for the Study of Lupus, Rosario, Argentina
Grupo Latino Americano de Estudio de Lupus or Latin America Group for the Study of Lupus, Rosario, Argentina
McGill University Health Center, Montreal, Canada
McGill University Health Center, Montreal, Canada
Grupo Latino Americano de Estudio de Lupus or Latin America Group for the Study of Lupus, Rosario, Argentina
Grupo Latino Americano de Estudio de Lupus or Latin America Group for the Study of Lupus, Rosario, Argentina
Grupo Latino Americano de Estudio de Lupus or Latin America Group for the Study of Lupus, Rosario, Argentina
Grupo Latino Americano de Estudio de Lupus or Latin America Group for the Study of Lupus, Rosario, Argentina
Grupo Latino Americano de Estudio de Lupus or Latin America Group for the Study of Lupus, Rosario, Argentina
Grupo Latino Americano de Estudio de Lupus or Latin America Group for the Study of Lupus, Rosario, Argentina
Grupo Latino Americano de Estudio de Lupus or Latin America Group for the Study of Lupus, Rosario, Argentina
Grupo Latino Americano de Estudio de Lupus or Latin America Group for the Study of Lupus, Rosario, Argentina
Grupo Latino Americano de Estudio de Lupus or Latin America Group for the Study of Lupus, Rosario, Argentina
Grupo Latino Americano de Estudio de Lupus or Latin America Group for the Study of Lupus, Rosario, Argentina
Grupo Latino Americano de Estudio de Lupus or Latin America Group for the Study of Lupus, Rosario, Argentina
Grupo Latino Americano de Estudio de Lupus or Latin America Group for the Study of Lupus, Rosario, Argentina
Grupo Latino Americano de Estudio de Lupus or Latin America Group for the Study of Lupus, Rosario, Argentina
Grupo Latino Americano de Estudio de Lupus or Latin America Group for the Study of Lupus, Rosario, Argentina
Grupo Latino Americano de Estudio de Lupus or Latin America Group for the Study of Lupus, Rosario, Argentina
Grupo Latino Americano de Estudio de Lupus or Latin America Group for the Study of Lupus, Rosario, Argentina
Grupo Latino Americano de Estudio de Lupus or Latin America Group for the Study of Lupus, Rosario, Argentina
Grupo Latino Americano de Estudio de Lupus or Latin America Group for the Study of Lupus, Rosario, Argentina
Unidad de Investigación en Enfermedades Crónico-Degenerativas, Guadalajara, México
The University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico, USA
Toronto Western Hospital Research Institute, University of Toronto, Toronto, Canada
Hospital Sierrallana, Torrelavega, Cantabria, Spain
Hospital García de Orta, Almada, Portugal
Grupo Latino Americano de Estudio de Lupus or Latin America Group for the Study of Lupus, Rosario, Argentina
Grupo Latino Americano de Estudio de Lupus or Latin America Group for the Study of Lupus, Rosario, Argentina
Cedars-Sinai Medical Center, Los Angeles, California, USA
Grupo Latino Americano de Estudio de Lupus or Latin America Group for the Study of Lupus, Rosario, Argentina
Grupo Latino Americano de Estudio de Lupus or Latin America Group for the Study of Lupus, Rosario, Argentina
Grupo Latino Americano de Estudio de Lupus or Latin America Group for the Study of Lupus, Rosario, Argentina
University of Texas Health Science Center, San Antonio, Texas, USA
The University of Alabama at Birmingham, Birmingham, Alabama, USA
The University of Texas Medical Branch, Galveston, Texas, USA
The University of Alabama at Birmingham, Birmingham, Alabama, USA
Harvard Medical School, Boston, Massachusetts, USA
Harvard Medical School, Boston, Massachusetts, USA
The National Databank for the Rheumatic Disease, Wichita, Kansas, USA
The University of Alabama at Birmingham, Birmingham, Alabama, USAgraciela.alarcon{at}ccc.uab.edu We have previously developed and validated a self-administered questionnaire, modelled after the Systemic Lupus International Collaborating Clinics Damage Index (SDI), the Lupus Damage Index Questionnaire (LDIQ), which may allow the ascertainment of this construct in systemic lupus erythematosus (SLE) patients followed in the community and thus expand observations made about damage. We have now translated, back-translated and adapted the LDIQ to Spanish, Portuguese and French and applied it to patients followed at academic and non-academic centres in North and South America, Portugal and Spain while their physicians scored the SDI. A total of 887 patients (659 Spanish-speaking, 140 Portuguese-speaking and 80 French-speaking patients) and 40 physicians participated. Overall, patients scored all LDIQ versions higher than their physicians (total score and all domains). Infrequent manifestations had less optimal clinimetric properties but overall agreement was more than 95% for the majority of items. Higher correlations were observed among the Spanish-speaking patients than the Portuguese-speaking and French-speaking patients; further adjustments may be needed before the Portuguese and French versions of the LDIQ are applied in community-based studies. The relationship between the LDIQ and other outcome parameters is currently being investigated in a different patient sample.
Key Words: damage French Portuguese SLE Spanish validation
Lupus, Vol. 18, No. 12,
1033-1052 (2009) |
||||